Antimicrobial 3: Antimycobacterials Flashcards
Name 2 main mycobacterial infections in humans:
tuberculosis (TB):
chronic infections caused by Mycobacterium tuberculosis
leprosy
chronic infections caused by Mycobacterium leprae
Mycobacterium are capable of surviving inside
macrophages after phagocytosis
tuberculosis (TB)
Characteristics
• TB usually affects the lungs and is associated with
chronic cough with blood-containing sputum
• Tuberculosis results almost exclusively through
inhalation of airborne particles that contain M.
tuberculosis
• Dispersed/spread through forced respiratory
maneuvers by those with active TB (e.g. coughing,
singing)
tuberculosis (TB)
Symptoms
Active pulmonary tuberculosis
symptoms:
- Most common symptom: Cough (becomes more
productive as disease progresses) - May have no symptoms aside from ”not feeling well”,
anorexia, fatigue, weight loss
Leprosy
Characteristics
• Leprosy mainly affects the skin and peripheral nerves
• Leprosy is an ancient disease that causes a chronic
disfiguring illness with long latency (2 types:
paucibacillary or multibacillary)
- Paucibacillary: T cell response dominated by interferon gamma - enhances macrophage’s ability To eliminate mycobacteria- treatment not as long
- Multibacillary: T cell response dominated by IL-4 response which can interfere with IF-gamma, macrophages fail to eradicate as good
• Spread person to person through nasal droplets and
secretions
Leprosy
Symptoms
Symptoms include non-pruritic rash, numbness and weakness of areas controlled by affected nerves
Not highly contagious - believed to be contagious due to appearance
Leprosy
Name 2 types of leprosy:
- tuberculoid leprosy
- lepromatous leprosy
Depending on type, different presentation of skin lesions, skin macules, papules, plaques
TB
Pharmacotherapy
- Initial phase of treatment includes isoniazid, rifampicin and pyrazinamide (and possibly ethambutol) for 2- months
- Continuation phase includes treatment with isoniazid and rifampicin for 4-months
• Combination therapy is used to avoid the development of drug resistance
Leprosy
Pharmacotherapy
- Tuberculoid leprosy treated with dapsone and
rifampicin for 6-months - Lepromatous leprosy treated with dapsone,
rifampicin, and clofazimine for 2-years
• Combination therapy is used to avoid the
development of drug resistance
Mycobacterial Cell Wall
Characteristics
• The mycobacterial cell wall is composed of a
peptidoglycan (PG) - arabinogalactan (AG) - mycolic
acid (MA) structure
- classified as G+ with peptidoglycan
• Mycobacteria, similar to gram negative bacteria, do
NOT retain the crystal violet stain. However, they are
classified as acid-fast gram positive bacteria due to
their lack of an outer cell membrane
tuberculosis (TB)
First-line Agents
Combination therapy is usually mandatory for TB to
decrease the probability of the emergence of resistant organisms
- Isoniazid
- Rifampicin
- Ethambutol
- Pyrazinamide
tuberculosis (TB)
Second-line Agents
Combination therapy is usually mandatory for TB to
decrease the probability of the emergence of resistant organisms
- Capreomycin
- Cycloserine
- Streptomycin
Note: these agents are used treat infections likely to be
resistant to first line agents or when first line agents are
abandoned due to adverse effects.
tuberculosis (TB) Agent
Isoniazid
Pharmacology
A prodrug that is activated by bacterial enzymes (katG) and subsequently inhibits synthesis of mycolic acids, an important component of the mycobacterium cell wall
- converted to isoniazid NAD complex, interferes with final step of mycolic acid syth, struggle to make cell wall
tuberculosis (TB) Agent
Isoniazid
AE
- Can cause * hemolytic anemia in people with glucose-
6-phosphate dehydrogenase deficiency - Other adverse effects include allergic skin eruptions,
fever, hepatotoxicity, arthritic symptoms & vasculitis
tuberculosis (TB) Agent
Rifampicin (aka Rifampin)
Pharmacology
Binds to and inhibits DNA-dependent RNA polymerase
only in prokaryotic cells
(not mammalian)
- mycobac cannot transcribe a mRNA to make proteins
tuberculosis (TB) Agent
Rifampicin (aka Rifampin)
AE
- Acute interstitial nephritis (rare)
- Orange tinge to saliva, tears, sweat
- (widely distributed in body fluids)
- Are infrequent but include skin eruptions, fever, GI
disturbances, & liver damage with jaundice